"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)".
Bengt RasmussenGudrun GöhringElsa BernardLars NilssonMagnus TobiassonMartin JäderstenHege GareliusIngunn DybedalKirsten GrønbaekElisabeth EjerbladFryderyk LorenzMax FlogegårdClaus Werenberg MarcherAnnette Öster FernströmLucia CavelierElli PapaemmanuilFreja EbelingAstrid Olsnes KittangJan Maxwell NørgaardLeonie SaftLars MöllgårdEva Hellström LindbergPublished in: Leukemia (2022)
Keyphrases
- phase ii study
- acute myeloid leukemia
- open label
- placebo controlled
- double blind
- phase iii
- phase ii
- locally advanced
- allogeneic hematopoietic stem cell transplantation
- clinical trial
- multiple myeloma
- study protocol
- newly diagnosed
- stem cell transplantation
- rectal cancer
- squamous cell carcinoma
- randomized controlled trial
- low dose
- high dose